{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T21:56:22Z","timestamp":1771970182860,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005485","name":"American College of Cardiology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006795","name":"Heart Failure Society of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005859","name":"Heart Rhythm Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005859","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100027858","name":"Association of Black Cardiologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100027858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cardfail.2024.12.001","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T03:03:01Z","timestamp":1738724581000},"page":"1326-1338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5806-3325","authenticated-orcid":false,"given":"Ilan","family":"Goldenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Ezekowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Albert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Alexis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elijah R.","family":"Behr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Daubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine E.","family":"Di Palo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth A.","family":"Ellenbogen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dillon J.","family":"Dzikowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen","family":"Hsich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Kutyifa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Lala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anekwe","family":"Onwuanyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ileana L.","family":"Pi\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roopinder K.","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Sears","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Sroubek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Strawderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Zareba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2024.12.001_bib1","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1161\/CIR.0b013e318276ce9b","volume":"127","author":"Epstein","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.001_bib2","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cardfail.2024.12.001_bib3","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2024.12.001_bib4","first-page":"e876","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.001_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.001_bib6","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.001_bib7","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.001_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.001_bib9","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/eurheartj\/ehz788","article-title":"The role of implantable cardioverter-defibrillators and sudden cardiac death prevention: indications, device selection, and outcome","volume":"41","author":"Goldenberg","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2024.12.001_bib10","first-page":"966","article-title":"Decline in ventricular arrhythmia events and mortality in the Multicenter Defibrillator Implantation Trials","volume":"16","author":"Kutyifa","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cardfail.2024.12.001_bib11","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.hrthm.2015.08.020","article-title":"Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: From the Israeli ICD Registry","volume":"12","author":"Sabbag","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cardfail.2024.12.001_bib12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.001_bib13","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.001_bib14","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.001_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCULATIONAHA.121.054034","article-title":"Implantable cardioverter-defibrillator eligibility after initiation of sacubitril\/valsartan in chronic heart failure: insights from PROVE-HF","volume":"144","author":"Felker","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.001_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jacc.2020.11.008","article-title":"Randomized trial of empagliflozin in nondiabetic patients with heart failure and reduced ejection fraction","volume":"77","author":"Santos-Gallego","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.001_bib17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/CIRCULATIONAHA.120.052186","article-title":"Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)","volume":"143","author":"Lee","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.001_bib18","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jama.1947.62890150005007a","article-title":"Ventricular fibrillation of long duration abolished by electric shock","volume":"135","author":"Beck","year":"1947","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.cardfail.2024.12.001_bib19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM195604192541601","article-title":"Termination of ventricular fibrillation in man by externally applied electric countershock","volume":"254","author":"Zoll","year":"1956","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.001_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJM198008073030607","article-title":"Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings","volume":"303","author":"Mirowski","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.001_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0735-1097(85)80186-8","article-title":"The automatic implantable cardioverter-defibrillator: an overview","volume":"6","author":"Mirowski","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.001_bib22","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.001_bib23","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.CIR.101.11.1297","article-title":"Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone","volume":"101","author":"Connolly","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.001_bib24","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.001_bib25","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2024.12.001_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009634","article-title":"Role of implantable cardioverter defibrillator in heart failure with contemporary medical therapy","volume":"15","author":"Butler","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.001_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2011.10.018","article-title":"Prophylactic cardioverter defibrillator utilization in the \"real world\": a conundrum","volume":"156","author":"Boriani","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.001_bib28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/europace\/euu296","article-title":"Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations","volume":"17","author":"Barra","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.cardfail.2024.12.001_bib29","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/CIRCULATIONAHA.110.989632","article-title":"Associations between outpatient heart failure process-of-care measures and mortality","volume":"123","author":"Fonarow","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.001_bib30","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1161\/CIRCULATIONAHA.110.940148","volume":"122","author":"Goldenberg","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.001_bib31","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.001_bib32","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/eurheartj\/ehz553","article-title":"What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?","volume":"41","author":"Packer","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2024.12.001_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609758","article-title":"Declining risk of sudden death in heart failure","volume":"377","author":"Shen","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.001_bib34","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.001_bib35","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/CIRCULATIONAHA.117.028829","article-title":"Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure","volume":"136","author":"Elming","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.001_bib36","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.hrthm.2010.07.005","article-title":"Time dependence of life-threatening ventricular tachyarrhythmias after coronary revascularization in MADIT-CRT","volume":"7","author":"Barsheshet","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cardfail.2024.12.001_bib37","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/europace\/euw157","article-title":"Replacement of implantable cardioverter defibrillators and cardiac resynchronization therapy devices: results of the European Heart Rhythm Association survey","volume":"18","author":"Tilz","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.cardfail.2024.12.001_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","article-title":"Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials","volume":"396","author":"Vaduganathan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2024.12.001_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jchf.2021.09.004","article-title":"A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction","volume":"10","author":"Tromp","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.001_bib40","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/eurheartj\/ehv186","article-title":"Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients","volume":"36","author":"Desai","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2024.12.001_bib41","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1007\/s00392-019-01440-y","article-title":"Sacubitril\/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction","volume":"108","author":"Martens","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.001_bib42","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jchf.2020.06.015","article-title":"Sacubitril\/valsartan and sudden cardiac death according to implantable cardioverter-defibrillator use and heart failure cause: a PARADIGM-HF analysis","volume":"8","author":"Rohde","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.001_bib43","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1093\/eurheartj\/ehab560","article-title":"Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF","volume":"42","author":"Curtain","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2024.12.001_bib44","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry","volume":"72","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.001_bib45","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1540-8159.2000.tb00877.x","article-title":"Patients\u2019 attitudes toward implanted defibrillator shocks","volume":"23","author":"Ahmad","year":"2000","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cardfail.2024.12.001_bib46","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa0706719","article-title":"Quality of life with defibrillator therapy or amiodarone in heart failure","volume":"359","author":"Mark","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.001_bib47","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/heart.87.5.488","article-title":"Quality of life and psychological functioning of ICD patients","volume":"87","author":"Sears","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.cardfail.2024.12.001_bib48","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1161\/CIRCULATIONAHA.105.577262","article-title":"Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II","volume":"113","author":"Goldenberg","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.001_bib49","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.12.001_bib50","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1093\/eurheartj\/ehac496","article-title":"Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial","volume":"43","author":"Knops","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2024.12.001_bib51","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jacep.2020.11.005","article-title":"Temporal incidence of appropriate and inappropriate therapy and mortality in secondary prevention ICD patients by cardiac diagnosis","volume":"7","author":"Ruwald","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cardfail.2024.12.001_bib52","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics\u20142022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.001_bib54","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.jacc.2006.03.032","article-title":"The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II","volume":"47","author":"Zwanziger","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.001_bib55","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1093\/eurheartj\/ehaa645","article-title":"The PROFID project","volume":"41","author":"Dagres","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2024.12.001_bib56","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2024.12.001_bib57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","article-title":"Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Di Marco","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.001_bib58","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/eurheartj\/ehy437","article-title":"Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar","volume":"40","author":"Gutman","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2024.12.001_bib59","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ahj.2019.10.020","article-title":"Myocardial fibrosis and the effect of primary prophylactic defibrillator implantation in patients with non-ischemic systolic heart failure\u2014DANISH-MRI","volume":"221","author":"Elming","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2024.12.001_bib60","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ahj.2023.09.008","volume":"266","author":"Flett","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2024.12.001_bib61","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/eurheartj\/ehaa1057","article-title":"Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score","volume":"42","author":"Younis","year":"2021","journal-title":"Eur Heart J"},{"issue":"Suppl","key":"10.1016\/j.cardfail.2024.12.001_bib62","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1016\/j.hrthm.2024.03.836","article-title":"Risk stratification for a primary prevention ICD: performance of the MADIT-ICD Benefit Score in a contemporary real world cohort","volume":"21","author":"Goldenberg","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cardfail.2024.12.001_bib63","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3390\/jpm12081240","article-title":"Usefulness of the MADIT-ICD benefit score in a large mixed patient cohort of primary prevention of sudden cardiac death","volume":"12","author":"Willy","year":"2022","journal-title":"Pers Med"},{"key":"10.1016\/j.cardfail.2024.12.001_bib64","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.2147\/IJGM.S359942","article-title":"Prediction efficiency of MADIT-ICD benefit score for outcome in Asian patients with implantable cardioverter-defibrillator","volume":"15","author":"Song","year":"2022","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.cardfail.2024.12.001_bib65","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/europace\/euac039","article-title":"The MADIT-ICD benefit score helps to select implantable cardioverter-defibrillator candidates in cardiac resynchronization therapy","volume":"24","author":"Dauw","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.cardfail.2024.12.001_bib76","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacc.2021.11.033","article-title":"Optimal background pharmacological therapy for heart failure patients in clinical trials","volume":"79","author":"Fiuzat","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.001_bib66","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.122.062159","article-title":"Declining risk of sudden cardiac death in heart failure: fact or myth?","volume":"147","author":"Leyva","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.001_bib67","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/eurheartj\/ehaa226","article-title":"EU-CERT-ICD SI. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study","volume":"41","author":"Zabel","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2024.12.001_bib68","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/CIRCULATIONAHA.119.043012","article-title":"Association between use of primary-prevention implantable cardioverter-defibrillators and mortality in patients with heart failure: a prospective propensity score-matched analysis from the Swedish Heart Failure Registry","volume":"140","author":"Uijl","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.001_bib69","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/eurheartj\/ehz773","article-title":"Time trends in sudden cardiac death risk in heart failure patients with cardiac resynchronization therapy: a systematic review","volume":"41","author":"Barra","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2024.12.001_bib70","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jacep.2024.102334","article-title":"Mortality benefit among primary prevention implantable cardioverter-defibrillator recipients on contemporary heart failure treatment","volume":"10","author":"Ahmed","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cardfail.2024.12.001_bib71","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/eurheartj\/ehx028","article-title":"Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials","volume":"38","author":"Shun-Shin","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2024.12.001_bib72","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/CIRCULATIONAHA.108.816884","article-title":"Maximizing survival benefit with primary prevention ICD therapy in a heart failure population","volume":"120","author":"Levy","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.001_bib73","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.jacc.2017.03.568","article-title":"Seattle Heart Failure Model (SHFM) for overall survival and the Seattle Proportional Risk Model (SPRM) Seattle heart failure and proportional risk models predict benefit from implantable cardioverter-defibrillators","volume":"69","author":"Bilchick","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.001_bib74","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jacc.2007.08.058","article-title":"Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction","volume":"51","author":"Goldenberg","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.001_bib75","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jchf.2019.12.015","article-title":"Contemporary treatment patterns and clinical outcomes of comorbid diabetes mellitus and HFrEF: the CHAMP-HF Registry","volume":"8","author":"Vaduganathan","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2024.12.001_bib77","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1093\/eurheartj\/ehae334","article-title":"Therapy duration and improvement of ventricular function in de novo heart failure: the Heart Failure Optimization study","volume":"45","author":"Veltmann","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2024.12.001_bib78","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2023.12.024","article-title":"2024 ACC Expert consensus decision pathway for treatment of heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"8","author":"Maddox","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.12.001_bib79","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/CIRCULATIONAHA.115.015677","article-title":"Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry)","volume":"132","author":"Kutyifa","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.12.001_bib80","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jacc.2012.05.057","article-title":"Effect of cardiac resynchronization therapy on the risk of first and recurrent ventricular tachyarrhythmic events in MADIT-CRT","volume":"60","author":"Ouellet","year":"2012","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916424009710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916424009710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:21:44Z","timestamp":1762363304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916424009710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":79,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1071916424009710"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2024.12.001","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2024.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Heart Rhythm Society and Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}